Genomics and epigenomics of colorectal cancer
- 16 January 2013
- journal article
- review article
- Published by Wiley in WIREs Mechanisms of Disease
- Vol. 5 (2) , 205-219
Abstract
Colorectal cancer is one of the most common cancer types worldwide and accounts for approximately 600,000 deaths annually. Work over the last decades has uncovered a number of tumor‐suppressor and oncogenes which are frequently mutated and might thus be responsible for the malignant transformation. However, only with the development of new high‐throughput technologies systematic analyses of the genome and epigenomes became feasible. While data generation has increased exponential, we are now faced with new challenges to transform these data into useful models that help predicting the outcome of genomic aberrations and to develop novel diagnostic and therapeutic strategies. As a basis for the modeling it is essential to understand and integrate current knowledge. We review previous and current ideas in colorectal cancer development and focus on a pathway oriented view. We show that colorectal cancer is a multilayer complex disease affecting the genome as well as the epigenome with direct consequences on the gene and microRNA (miRNA) expression signatures. The goal is to illustrate the current principles of colorectal cancer pathogenesis and to illustrate the need for elaborate computer modeling systems. WIREs Syst Biol Med 2013, 5:205–219. doi: 10.1002/wsbm.1206This article is categorized under: Analytical and Computational Methods > Analytical Methods Laboratory Methods and Technologies > Genetic/Genomic Methods Translational, Genomic, and Systems Medicine > Therapeutic Methods Translational, Genomic, and Systems Medicine > Translational MedicineKeywords
This publication has 148 references indexed in Scilit:
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumorsGenes, Chromosomes and Cancer, 2010
- Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progressionTumor Biology, 2010
- The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancersGenes, Chromosomes and Cancer, 2008
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- The methylome: approaches for global DNA methylation profilingTrends in Genetics, 2008
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes ApoptosisMolecular Cell, 2007
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996